Join Crystal Pharmatech at AAPS PharmSci 360, from October 25–28, 2026, in New Orleans, LA.
As a technology-driven CRO/CDMO, we invite you to discover how our "First-Time-Right" approach delivers strategic, phase-appropriate solutions that de-risk drug development and accelerate your development of new medicines.
What you will take away from Crystal Pharmatech:
Our experts will lead in-depth discussions on how our three specialized platforms can de-risk your 2026 development goals:
Small Molecule: Solid-State Research, Preformulation, and CMC Formulation Development through to GMP Manufacturing (First-Time-Right approach).
Biologics (Crystal Bio Solutions): Biologics Characterization & CMC Analytical services, Bioanalysis & Biomarker, and Quantitative Clinical Pharmacology.
Nucleic Acids (Crystal NAX): End-to-end solutions for nucleic acid therapeutics.
CEO of Canada CDMO BU
Candoo Pharmatech
CEO of China CDMO BU
Crystal Formulation Services
Olivia Liu
Associate Director of BD
Crystal Formulation Services
Business Development Director
Crystal Pharmatech
Head of West Coast Business
Crystal Bio Solutions
When: October 25-28, 2026
Where: Ernest N. Morial Convention Center, New Orleans, LA
Subscribe to be the first to get the updates!
